Jennifer King is Intellia’s Senior Vice President for Business Development, where she is responsible for accessing external sources of innovation and establishing the company’s key industry partnerships. She was appointed to her current position in March, 2017.

Jennifer brings nearly 20 years of operating experience in the biopharmaceutical industry. Prior to her joining Intellia in June, 2015 she held the position of Senior Director of Business Development at Shire Plc, where she was responsible for the sourcing, initial evaluation and negotiation of licensing and acquisition opportunities within the company’s corporate development group. She previously worked in Shire’s rare disease commercial organization as a Global Brand Director for two clinical stage programs. She also served as its Director of New Products, where she was responsible for providing commercial guidance to development and research stage projects, as well as evaluating the commercial attractiveness of business development opportunities. Before joining Shire in 2006, Jennifer held a variety of commercial roles in at Millennium Pharmaceuticals; most notably as the Product Manager for the US launch of VELCADE®.

Jennifer received her B.S. in Biology from the Massachusetts Institute of Technology, earned a Ph.D. in Developmental Biology at the Stanford University School of Medicine, and was awarded her MBA by Northeastern University.